rs2855437

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_080680.3(COL11A2):​c.3313-11C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.711 in 1,610,246 control chromosomes in the GnomAD database, including 409,716 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.74 ( 41958 hom., cov: 31)
Exomes 𝑓: 0.71 ( 367758 hom. )

Consequence

COL11A2
NM_080680.3 intron

Scores

2
Splicing: ADA: 0.00001617
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:18

Conservation

PhyloP100: 0.398
Variant links:
Genes affected
COL11A2 (HGNC:2187): (collagen type XI alpha 2 chain) This gene encodes one of the two alpha chains of type XI collagen, a minor fibrillar collagen. It is located on chromosome 6 very close to but separate from the gene for retinoid X receptor beta. Type XI collagen is a heterotrimer but the third alpha chain is a post-translationally modified alpha 1 type II chain. Proteolytic processing of this type XI chain produces PARP, a proline/arginine-rich protein that is an amino terminal domain. Mutations in this gene are associated with type III Stickler syndrome, otospondylomegaepiphyseal dysplasia (OSMED syndrome), Weissenbacher-Zweymuller syndrome, autosomal dominant non-syndromic sensorineural type 13 deafness (DFNA13), and autosomal recessive non-syndromic sensorineural type 53 deafness (DFNB53). Alternative splicing results in multiple transcript variants. A related pseudogene is located nearby on chromosome 6. [provided by RefSeq, Jul 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 6-33171178-G-A is Benign according to our data. Variant chr6-33171178-G-A is described in ClinVar as [Benign]. Clinvar id is 46566.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-33171178-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.879 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL11A2NM_080680.3 linkc.3313-11C>T intron_variant Intron 44 of 65 ENST00000341947.7 NP_542411.2 P13942A0A0C4DFS1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL11A2ENST00000341947.7 linkc.3313-11C>T intron_variant Intron 44 of 65 5 NM_080680.3 ENSP00000339915.2 A0A0C4DFS1
COL11A2ENST00000374708.8 linkc.3055-11C>T intron_variant Intron 42 of 63 5 ENSP00000363840.4 Q4VXY6
COL11A2ENST00000477772.1 linkn.273-5362C>T intron_variant Intron 5 of 8 2

Frequencies

GnomAD3 genomes
AF:
0.740
AC:
112418
AN:
151924
Hom.:
41911
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.801
Gnomad AMI
AF:
0.585
Gnomad AMR
AF:
0.743
Gnomad ASJ
AF:
0.759
Gnomad EAS
AF:
0.900
Gnomad SAS
AF:
0.827
Gnomad FIN
AF:
0.701
Gnomad MID
AF:
0.783
Gnomad NFE
AF:
0.691
Gnomad OTH
AF:
0.741
GnomAD3 exomes
AF:
0.744
AC:
181785
AN:
244222
Hom.:
68188
AF XY:
0.746
AC XY:
98435
AN XY:
132026
show subpopulations
Gnomad AFR exome
AF:
0.805
Gnomad AMR exome
AF:
0.765
Gnomad ASJ exome
AF:
0.769
Gnomad EAS exome
AF:
0.907
Gnomad SAS exome
AF:
0.827
Gnomad FIN exome
AF:
0.694
Gnomad NFE exome
AF:
0.688
Gnomad OTH exome
AF:
0.734
GnomAD4 exome
AF:
0.708
AC:
1031882
AN:
1458204
Hom.:
367758
Cov.:
61
AF XY:
0.711
AC XY:
515820
AN XY:
725120
show subpopulations
Gnomad4 AFR exome
AF:
0.814
Gnomad4 AMR exome
AF:
0.765
Gnomad4 ASJ exome
AF:
0.767
Gnomad4 EAS exome
AF:
0.945
Gnomad4 SAS exome
AF:
0.825
Gnomad4 FIN exome
AF:
0.695
Gnomad4 NFE exome
AF:
0.683
Gnomad4 OTH exome
AF:
0.711
GnomAD4 genome
AF:
0.740
AC:
112521
AN:
152042
Hom.:
41958
Cov.:
31
AF XY:
0.741
AC XY:
55112
AN XY:
74332
show subpopulations
Gnomad4 AFR
AF:
0.801
Gnomad4 AMR
AF:
0.742
Gnomad4 ASJ
AF:
0.759
Gnomad4 EAS
AF:
0.900
Gnomad4 SAS
AF:
0.828
Gnomad4 FIN
AF:
0.701
Gnomad4 NFE
AF:
0.691
Gnomad4 OTH
AF:
0.744
Alfa
AF:
0.712
Hom.:
65177
Bravo
AF:
0.745
Asia WGS
AF:
0.818
AC:
2844
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:18
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:8
May 07, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

3313-11C>T in Intron 44 of COL11A2: This variant is not expected to have clinica l significance because it has been identified in 31.5% (2213/7016) of European A merican chromosomes from a broad population by the NHLBI Exome Sequencing Projec t (http://evs.gs.washington.edu/EVS; dbSNP rs2855437). -

Mar 21, 2016
Eurofins Ntd Llc (ga)
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Sep 29, 2016
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Otospondylomegaepiphyseal dysplasia, autosomal dominant Benign:2
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Otospondylomegaepiphyseal dysplasia, autosomal recessive Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Fibrochondrogenesis 2 Benign:2
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Autosomal recessive nonsyndromic hearing loss 53 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Autosomal dominant nonsyndromic hearing loss 13 Benign:1
Jul 22, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Stickler Syndrome, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
2.9
DANN
Benign
0.41

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000016
dbscSNV1_RF
Benign
0.0
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2855437; hg19: chr6-33138955; API